
Profound Medical Corp. PROF
$ 6.18
3.87%
Annual report 2023
added 12-27-2025
Profound Medical Corp. P/CF Ratio 2011-2026 | PROF
Annual P/CF Ratio Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -10.3 | -11.1 | -8.07 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -8.07 | -11.1 | -9.81 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
45.7 | $ 11.28 | 3.44 % | $ 1.69 B | ||
|
Cytosorbents Corporation
CTSO
|
-2.82 | $ 0.59 | -2.72 % | $ 36.7 M | ||
|
AxoGen
AXGN
|
1.84 K | $ 32.48 | 1.63 % | $ 1.5 B | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 3.32 | 0.61 % | $ 124 M | ||
|
Helius Medical Technologies
HSDT
|
-0.34 | $ 1.94 | 2.77 % | $ 1.18 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | ||
|
Align Technology
ALGN
|
18.9 | $ 179.07 | 3.42 % | $ 13.4 B | ||
|
AdaptHealth Corp.
AHCO
|
2 | $ 12.3 | 1.07 % | $ 1.66 B | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
IRIDEX Corporation
IRIX
|
-7.85 | $ 1.01 | 1.01 % | $ 17.1 M | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
17.2 | $ 286.97 | 2.76 % | $ 8.1 B | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
0.000028 | $ 38.78 | 3.17 % | $ 5.78 K | ||
|
LivaNova PLC
LIVN
|
15 | $ 64.22 | 2.3 % | $ 3.5 B | ||
|
LENSAR
LNSR
|
-4.81 | $ 5.77 | 1.23 % | $ 69 M | ||
|
Boston Scientific Corporation
BSX
|
24.9 | $ 62.75 | 1.55 % | $ 92.9 B | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-13.2 | $ 9.67 | 11.41 % | $ 274 M | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
15.3 | $ 24.4 | 1.16 % | $ 206 M | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
-10.8 | - | -0.97 % | $ 54.4 M | ||
|
Inogen
INGN
|
-14.3 | $ 6.42 | 1.42 % | $ 171 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-90 | $ 16.76 | 4.95 % | $ 393 M | ||
|
Globus Medical
GMED
|
16.6 | $ 92.24 | 2.01 % | $ 12.5 B | ||
|
Butterfly Network
BFLY
|
-18.4 | $ 4.14 | 0.61 % | $ 876 M | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
Stryker Corporation
SYK
|
34.6 | $ 343.83 | 1.38 % | $ 131 B | ||
|
Delcath Systems
DCTH
|
14.5 | $ 10.32 | 2.79 % | $ 370 M | ||
|
TELA Bio
TELA
|
-1.15 | $ 0.55 | -2.71 % | $ 25.8 M | ||
|
Myomo
MYO
|
-2.34 | $ 0.71 | 2.39 % | $ 29.7 M | ||
|
Inspire Medical Systems
INSP
|
15.1 | $ 54.05 | 0.06 % | $ 1.59 B | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 37.82 | 2.94 % | $ 1.17 B | ||
|
TransMedics Group
TMDX
|
24.3 | $ 113.3 | -0.61 % | $ 3.85 B |